France· FR:63412825
NINTEDANIB EG 100 mg, capsule molle
A medicinal product containing ésilate de nintédanib, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉSILATE DE NINTÉDANIB
- Manufacturer
- EG LABO - LABORATOIRES EUROGENERICS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093028907560 plaquettes prédécoupées unitaires OPA : polyamide orienté aluminium PVC-Aluminium de 1 capsule(s)EUR 607.14
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ésilate de nintédanib in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandAgarfNorameda UAB
- SpainNINTEDANIB ACCORD 100 MG CAPSULAS BLANDAS EFGAccord Healthcare S.L.U.
- SwedenNintedanib Accord 100 mg Kapsel, mjukAccord Healthcare S.L.U.
- PolandNintedanib AccordAccord Healthcare S.L.U.
- SwitzerlandNintedanib Leman 100 mg, capsule molleLeman SKL SA
- IrelandOfev 100 mg Soft capsuleBoehringer Ingelheim International GmbH
- NorwayNintedanib AccordAccord Healthcare S.L.
- NetherlandsGevesla 100 mg, zachte capsulesSandoz B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Nintedanib Cipla, Nintedanib Ratiopharm
- Belgium · Nintedanib Accordpharma, Nintedanib Eg
- Cyprus · Nintedanib Teva
- Czechia · Nintedanib Glenmark, Nintedanib Sandoz
- Germany · Nintedanib, Nintedanib 1 A Pharma
- Denmark · Nintedanib "sandoz", Nintedanib Glenmark
- Estonia · Agarf, Nintedanib Sandoz
- Spain · Nintedanib, Nintedanib Accordpharma
- Finland · Nintedanib Glenmark, Nintedanib Ratiopharm
- United Kingdom (Northern Ireland) · Nintedanib, Nintedanib Accord Healthcare
- Greece · Nifib, Nindraf
- Croatia · Gevesla, Nintedanib Accordpharma
- Hungary · Nintedanib Accordpharma, Nintedanib Onkogen
- Ireland · Nintedanib Accordpharma, Nintedanib Clonmel
- Iceland · Agarf, Nintedanib Accord
- Italy · Nintedanib Accordpharma, Nintedanib Aurobindo
- Liechtenstein · Nintedanib Accord, Nintedanib Viatris
- Lithuania · Agarf, Nintedanib Sandoz
- Luxembourg · Nintedanib Eg, Nintedanib Eurogenerics
- Latvia · Agarf, Nintedanib Sandoz
- Malta · Nifiden Adalvo, Nintedanib Adalvo
- Netherlands · Gevesla, Nintedanair
- Norway · Nintedanib Accord, Nintedanib Devatis
- Poland · Nintedanib, Nintedanib Accordpharma
- Portugal · Nintedanib Accordpharma, Nintedanib Eugia
- Romania · Gevesla, Nintedanib Dr. Reddy’s
- Sweden · Nintedanib Devatis, Nintedanib Glenmark
- Slovenia · Nintedanib Accordpharma, Nintedanib Stada
- Slovakia · Nintedanib Stada, Nintedanib Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab8694ff-32e9-4efd-b9ef-c96faecb7656 GET /v1/drugs/ab8694ff-32e9-4efd-b9ef-c96faecb7656?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63412825",
"date_amm": "2024-01-26",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "ÉSILATE DE NINTÉDANIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "capsule molle",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ésilate de nintédanib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.